Synthesis of New Dihydroquinopimaric Acid Analogs with Nitrile Groups as Apoptosis-Inducing Anticancer Agents

Author:

Tretyakova Elena V.1,Salimova Elena V.1,Parfenova Lyudmila V.1,Yunusbaeva Milyausha M.1,Dzhemileva Lilya U.1,D’yakonov Vladimir A.1,Dzhemilev Usein M.1

Affiliation:

1. Institute of Petrochemistry and Catalysis of Russian Academy of Sciences, 141 Prospekt Oktyabrya, Ufa 450075, Russian Federation

Abstract

Background: Cyan-containing compounds are of great interest as potential anticancer agents. Terpenoids can severe as a natural matrix for the development of promising derivatives with antitumor activity. Methods: The 2-cyanoethoxy methyl dihydroquinopimarate derivatives (5-9) were synthesized by the reaction of the intermediates (1-4) with acrylonitrile in the presence of alkali (30% KOH solution) using triethylbenzylammonium chloride. The cytotoxicity evaluation was carried out according to the National Cancer Institute (NCI) Protocol, while apoptosis was studied by flow cytometric analysis of Annexin V and 7-aminoactinomycin D staining and cell cycle was analyzed using the method of propidium iodide staining. Results: Synthesis of new dihydroquinopimaric acid derivatives with nitrile groups was carried out. The obtained cyanoethyl derivatives were converted into tetrazole, amine, oxadiazole and amidoxime analogs. The primary screening for antitumor activity showed the highest cytotoxic potency of the cyanoethyl-substituted compounds. The introduction of cyanoethyl groups at C-1, C-4 and C-1, C-4, C-20 positions of dihydroquinopimaric acid methyl ester provided antiproliferative effect towards the Jurkat, K562, U937, and HeLa tumor cell cultures (CC50=0.045-0.154µM). These nitrile derivatives are effective inducers of tumor cell apoptosis affecting the S and G2 phases of the cell cycle in a dose-dependent manner. Conclusion: The cyanoethyl analogs of dihydroquinopimaric acid reported herein are apoptosis inducers and cytotoxic agents. These findings will be useful for the further design of more potent cytotoxic agents based on natural terpenes.

Funder

President of Russian Federation

Russian Foundation for Basic Research

Russian Science Foundation

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Reference40 articles.

1. Palumbo M.O.; Kavan P.; Miller Jr., W.H.; Panasci L.; Assouline S.; Johnson N.; Cohen V.; Patenaude F.; Pollak M.; Jagoe R.T.; Batist G.; Systemic cancer therapy: Achievements and challenges that lie ahead. Front Pharmacol 2013,4,57

2. Roubille C.; Richer V.; Starnino T.; McCourt C.; McFarlane A.; Fleming P.; Siu S.; Kraft J.; Lynde C.; Pope J.; Gulliver W.; Keeling S.; Dutz J.; Bessette L.; Bissonnette R.; Haraoui B.; The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis. Ann Rheum Dis 2015,74,480-489

3. Deyab G.; Hokstad I.; Whist J.E.; Smastuen M.C.; Agewall S.; Lyberg T.; Ronda N.; Mikkelsen K.; Hjeltnes G.; Hollan I.; Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis. Arthritis Res Ther 2017,19,232-244

4. Montaudie H.; Sbidian E.; Paul C.; Maza A.; Gallini A.; Aractingi S.; Aubin F.; Bachelez H.; Cribier B.; Joly P.; Jullien D.; Le Maitre M.; Misery L.; Richard M-A.; Ortonne J-P.; Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 2011,25(2),1-33

5. Youm I.; West M.B.; Li W.; Du X.; Ewert D.L.; Kopke R.D.; siRNA-loaded biodegradable nanocarriers for therapeutic MAPK1 silencing against cisplatin-induced ototoxicity. Int J Pharm 2017,528,611-623

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3